1613591-54-0

Basic information

• Product Name: C₃₆H₃₈F₂N₅O₇P
• Synonyms: C₃₆H₃₈F₂N₅O₇P
• CAS NO: 1613591-54-0
• Molecular Weight: 721.698
• Mol File: 1613591-54-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: C₃₆H₃₈F₂N₅O₇P(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₆H₃₈F₂N₅O₇P(1613591-54-0)
• EPA Substance Registry System: C₃₆H₃₈F₂N₅O₇P(1613591-54-0)

Safety Data

• Hazardous Substances Data: 1613591-54-0(Hazardous Substances Data)

Upstream product

• 1613589-81-3 C₆₀H₅₃F₂N₅O₇ 
• 1613589-80-2 C₅₃H₄₈F₂IN₅O₅ 
• 261909-49-3 phenyl(isopropoxy-L-alaninyl) phosphorochloridate 
• 1613589-75-5 9-(2-deoxy-2,4-difluoro-2-C-methyl-β-D-ribofuranosyl)-6-ethoxy-2-((4-monomethoxytrityl)amino)purine 
• 56376-11-5 isopropyl phosphorodichloridate 
• 1613589-82-4 C₅₃H₄₉F₂N₅O₆ 
• 1613591-30-2 C₄₅H₃₇ClFN₅O₆ 
• 879551-04-9 (3R,4R,5R)-3?fluoro?4?hydroxy?5?(hydroxymethyl)?3?methyltetrahydrofuran?2?one 
• 879551-01-6 (4S,5R)-ethyl-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-meth-yl-1,3,2-dioxathiolane-4-carboxylate 2,2-dioxide 
• 1613589-74-4 9-(3,5-di-O-benzoyl-2-deoxy-2,4-difluoro-2-C-methyl-β-D-ribofuranosyl)-6-ethoxy-2-((4-monomethoxytrityl)amino)purine 
• 1613589-73-3 C₄₀H₃₆F₂IN₅O₅ 
• 1613589-72-2 9-(2,5-dideoxy-2,4-difluoro-5-iodo-2-C-methyl-β-D-ribofuranosyl)-6-ethoxy-2-((4-monomethoxytrityl)amino)purine 
• 1613589-71-1 9-(4,5-didehydro-2,5-dideoxy-2-fluoro-2-C-methyl-β-D-ribofuranosyl)-6-ethoxy-2-((4-monomethoxytrityl)amino)purine 
• 1613589-70-0 9-(2,5-dideoxy-2-fluoro-2-C-methyl-5-iodo-β-D-ribofuranosyl)-6-ethoxy-2-((4-monomethoxytrityl)amino)purine 

Relevant articles and documents

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

Disclosed herein are nucleosides, nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a Filoviridae virus infection with one or more nucleosides and/or nucleotide analogs.

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a Coronaviridae virus, a Togaviridae virus, a Hepeviridae virus and/or a Bunyaviridae virus infection with one or more nucleosides, nucleotides and nucleotide analogs.